Summary: In a recent New Atlas article, Rich Haridy thoroughly explores the evolution of opinions within the psychedelic community about what ending the drug war could look like. Haridy highlights the 36 years of work that MAPS Founder and Executive Director Rick Doblin, Ph.D., and the MAPS team have done to scientifically establish the potential medical value of psychedelics. “Despite the fact that paltry scientific evidence was presented or sought to justify their criminalization when psychedelic substances were originally outlawed, the only way, besides Congressional intervention, to take them out of Schedule I – the most restrictive category – is to prove to the FDA that they are, in fact, safe for humans to take, have medical value, and are not as prone to abuse as originally asserted,” says MAPS Director of Policy and Advocacy Ismail Lourido Ali, J.D.